Relationship among permeation of ethanol, leaching of hemoglobin from capillary blood, and permeation of morphine hydrochloride in hairless rat skin

Drug Delivery System

Volumn 15, Issue 2, 2000, Pages 121-126

  Seki, Toshinobu ^a,b   Wada, Yoshio ^b   Kobayashi, Nobuko ^a   Juni, Kazuhiko ^a   Morimoto, Yasunori ^a,b  

^a JOSAI UNIVERSITY   (Japan)

^b Research Institute TTS Technology   (Japan)

Author keywords

ethanol; Fe content; morphine hydrochloride; skin irritation; skin permeation

Indexed keywords

EID: 0007645773     PISSN: 09135006     EISSN: 18812732     Source Type: Journal    
DOI: 10.2745/dds.15.121     Document Type: Article

References (13)

1. Hsieh DS(ed) : Drug permeation enhancement. Marcel Dekker, New York, 1994.
2. Bando H, Takagi T, Yamashita F, Takakura Y, Hashida M : Theoretical design of prodrugs-enhancer combination based on a skin diffusion model : Prediction of permeation of acyclovir prodrugs treated with 1-geranylazacycloheptan-2-one. Pharm Res 13 : 427-439, 1996.
3. Sugibayashi K, Nakayama S, Seki T, Hosoya K, Morimoto Y : Mechanism of skin penetration-enhancing effect by laurocapram. J Pharm Sci 81 : 58-64, 1992.
4. Hori M, Maibach HI, Guy R : Enhancement of propranolol hydrochloride and diazepam skin absorption in vitro. II Drug, vehicle, and enhancer penetration kinetics. J Pharm Sci 81 : 330-333, 1992.
5. Friend DR, Smedley SI : Solvent drag in ethanol/ethyl acetate enhanced skin permeation of d-norgestrel. Int J Pharmaceut 97 : 39-46, 1993.
6. Tata S, Flynn GL, Weiner ND : Penetration of minoxidil from ethanol/propylene glycol solutions : Effect of application volume and occlusion. J Pharm Sci 84 : 688-691, 1995.
7. Kobayashi D, Matsuzawa T, Sugibayashi K, Morimoto Y, Kobayashi M et al. : Feasibility of use of several cardiovascular agents in transdermal therapeutic systems with l-menthol-ethanol system on hairless rat and human skin. Biol Pharm Bull 16 : 254-258, 1993.
8. Altenburger R, Rohr UD, Kissel T : Rate control in transdermal β-estradiol reservoir membrane systems : The role of membrane and adhesive layer. Pharm Res 15 : 1238-1243, 1998.
9. Nangia A, Camel E, Berner B, Maibach HI : Influence of skin irritants on percutaneous absorption. Pharm Res 10 : 1756-1759, 1993.
10. Sugibayashi K, Sakanoue C, Morimoto Y : Utility of topical formulations of morphine hydrochloride containing Azone and N-metyl-2 pyrrolidone. Selective Cancer Ther 5 : 119-128, 1989.
11. Wada Y, Nakajima K, Yamazaki J, Seki T, Sugibayashi K et al. : Influence of composition of l-menthol-ethanol-water ternary solvent system on the transdermal delivery of morphine hydrochloride. Biol Pharm Bull 16 : 600-603, 1993.
12. Matsuzawa T, Wada Y, Shimoyama M, Nakajima K, Seki T et al. : The effect of different routes of administration on the metabolism of morphine : The disposition of morphine and its metabolites after topical application. Biopharm Drug Dispos 15 : 665-678, 1994.
13. Hatanaka T, Manabe E, Sugibayashi K, Morimoto Y : An application of the hydrodynamic pore theory to percutaneous absorption of drugs. Pharm Res 11 : 654-657, 1994.